The largest database of trusted experimental protocols

1 148 protocols using living image software

1

In Vivo Fluorescence Imaging of Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon arrival at Northwestern University, tissues were washed with PBS then imaged on an IVIS Lumina Series III (Perkin Elmer) using the fluorescent imaging settings. Whole organs or large pieces of tissue were imaged using the same exposure conditions for each fluorophore, respectively (Cy3 and Cy5). The lungs were further separated into individual lobes and imaged again under identical conditions. Small pieces of tissue (~2x2cm2) were cut from whole organs and re-imaged on the IVIS before being frozen in OCT in cryomolds. Imaging conditions were kept consistent between animals that received the same fluorophore and all resulting images were set to the same scale before analysis using the Living Image Software (Perkin Elmer).
Quantification of fluorescent signal was carried out using the Living Image Software. Regions of interest (ROIs) were created automatically by the software and adjusted manually to cover each tissue piece individually (Supplementary Figure 1A). Signal is reported as total radiant efficiency, which is a unit less measure that uses photons per second then normalizes based on wattage and intensity of the excitation light. The average radiant efficiency value normalizes the total value by the size of each ROI.
+ Open protocol
+ Expand
2

In vivo and ex vivo bioluminescence imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vivo imaging: for the semi-quantitative analysis of photon emission, animals were injected i.p. with 80 mg/kg of luciferin (Beetle Luciferin Potassium Salt; Promega, Madison, WI, USA) 15 min prior the imaging session. For the imaging, mice were anaesthetized using Isofluorane (Isofluorane-Vet; Merial, Lyon, France) and kept under anesthesia during the 5 min of the session carried out with a CCD-camera (IVIS Lumina II Quantitative Fluorescent and Bioluminescent Imaging; PerkinElmer, Waltham, MA, USA). Photon emission in selected body areas was measured, respectively, using the Living Image Software (PerkinElmer).
Ex vivo imaging: the selected organs were dissected from mice treated with luciferine 15 min prior euthanasia and subjected to ex vivo imaging immediately after death. Imaging analysis was done by 5 min exposures of the tissue explants. Photon emission was quantified with the Living Image Software (PerkinElmer).
+ Open protocol
+ Expand
3

Hep-3B Tumor Xenograft and Metastasis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were performed in compliance with all relevant ethical regulations and in accordance with an Institutional Animal Care and Use Committee-approved protocol (No. 18080B). NCG mice (GuangDong GemPharmatech Co., Ltd.) aged 4–6 weeks were inoculated subcutaneously with 2.5 × 106 tumour cells (Hep-3B-luc), and after the tumour grew to 50–100 mm3, Mock T, CD133 CAR-T and CD133 CAR-T and PD-1 s cells were intravenously injected into NCG mice with Hep-3B. For metastatic mouse models, the NCG mice were intravenously injected with 2.5 million Hep3B-luc cells. The metastasis was confirmed by bioluminescence imaging (BLI) and then treated with a tail veil injection of 5 million Mock T, CD133 CAR-T or CD133 CAR-T and PD-1 s cells. BLI of tumour growth was performed using a PerkinElmer IVIS imaging system with Living Image software. Finally, the tumour weight was evaluated. Mice were euthanized when the tumour volume reached 2000 mm3 or when they showed any sign of sickness. For establishment of an in situ xenograft tumour model, 2.5 million Hep3B-luc cells were directly injected into the liver of NCG mice. The tumour was confirmed by BLI, and 5 million Mock T, CD133 CAR-T or CD133 CAR-T and PD-1 s cells were injected into the tail vein. BLI of tumour growth was performed using a PerkinElmer IVIS imaging system with Living Image software.
+ Open protocol
+ Expand
4

In Vivo Bioluminescence Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bioluminescence imaging was performed using the IVIS Spectrum (PerkinElmer, Villebon-sur-Yvette, France) imaging scanner coupled to the Living Image Software (Perkin Elmer) on IVIA multimodal imaging platform (Clermont-Ferrand, France) (https://doi.org/10.18145/ivia accessed on 17 May 2022). Briefly, 100 mg/kg of in vivo luciferase substrate (beetle luciferin substrate, Promega) were injected intraperitoneally into each CARE-LUC mouse. Mice were then anesthetized with isoflurane and scanned 10 min after luciferin injection. The abdominal cavity was shaved to allow for the accurate collection of bioluminescence signals. Light emission was quantified with imaging software from constant regions of interest (ROI) drawn manually. Photon emission was measured as radiance in p·s−1·cm−2·sr−1. The sensitivity of the imaging scanner was tested weekly with commercially available positive sources of bioluminescence. Excised organs were imaged immediately after euthanasia using the IVIS Spectrum (PerkinElmer) imaging scanner coupled to the Living Image Software (PerkinElmer).
+ Open protocol
+ Expand
5

Tumor Growth Monitoring by Bioluminescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
To track tumor growth, luciferase luminescence was detected using a Xenogen IVIS Spectrum imaging system (PerkinElmer) as previously described.25 Briefly, 200 μL of 15 mg/mL D‐luciferin was injected into the mice abdomen and the bioluminescent signal evaluated after 10 min to obtain the peak photon emission per second. The signal was quantified using the Living Image software (PerkinElmer) and the total photon flux emission (photons/second) in the regions of interest (ROI) recorded, starting at day 8 after tumor cell injection. Images were normalized using the Living Image software (PerkinElmer) with a minimum and maximum radiance of 1.7 × 104 and 9.7 × 104 photons/s, respectively.
+ Open protocol
+ Expand
6

In Vivo Bioluminescent Imaging of Mice and Embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo bioluminescent imaging adult mice were intraperitoneal (IP) injected with 0.15 mg/g D-Luciferin (Perkin Elmer), dissolved in dH2O. Mice were left conscious for 3 min to allow the D-Luciferin to circulate, then anesthetized with isoflurane. 10 min post injection mice were imaged using the IVIS Spectrum (Perkin Elmer) and Living Image software (version 4.3.1). Adult mice were imaged using field of view (FOV) C or D, bin 1 with 15 s exposure time using a stage temperature of 37°C. Dissected tissues were incubated in 150 μg/ml D-Luciferin in PBS for 10 min prior to imaging.
For imaging of embryos, pregnant females were IP injected with 0.15 mg/g D-Luciferin, and embryos dissected 12 min post injection. Dissected embryos were placed in 24 well plates and incubated in 150 μg/ml D-Luciferin in PBS for 10 min prior to imaging on the IVIS Spectrum. Embryos were imaged using FOV A, bin 4 and 60 s exposure.
All single reporter imaging was performed using the ‘open’ emission filter. Image analysis was performed using the Living Image software (version 4.5.2) (Perkin Elmer). For bioluminescence quantification, regions of interest (ROI) were drawn around animals, embryos or tissues to calculate flux (p/s) and average radiance (p/s/cm2/sr) within the region.
+ Open protocol
+ Expand
7

In Vivo Tumor Imaging of Nalm6 Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCG mice were i.v. inoculated with 1x106 Nalm6 tumor cells transduced with GFP/luciferase on day 0, randomized, followed by treatment with 1x105 human CAR T cells on day 4. At indicated time points, tumor-bearing mice were i.p. injected with D-Luciferin (Gold Biotechnology) (150 mg/kg) and imaged using the IVIS Imaging System (PerkinElmer) with Living Image software (PerkinElmer), under the settings of 22.6 cm field of view, medium binning level, and 30-second exposure time. Data were analyzed using Living Image software (Perkin Elmer). Tumor burden was quantified as described (25 (link)).
+ Open protocol
+ Expand
8

In Vivo Tumor Imaging of Nalm6 Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCG mice were i.v. inoculated with 1x106 Nalm6 tumor cells transduced with GFP/luciferase on day 0, randomized, followed by treatment with 1x105 human CAR T cells on day 4. At indicated time points, tumor-bearing mice were i.p. injected with D-Luciferin (Gold Biotechnology) (150 mg/kg) and imaged using the IVIS Imaging System (PerkinElmer) with Living Image software (PerkinElmer), under the settings of 22.6 cm field of view, medium binning level, and 30-second exposure time. Data were analyzed using Living Image software (Perkin Elmer). Tumor burden was quantified as described (25 (link)).
+ Open protocol
+ Expand
9

Subcutaneous U251-luc Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six to eight-week-old female severely immune-deficient NOD-Prkdcem26Cd52Il2rgem26Cd22/Nju (NCG, T001475) mice were purchased from the GemPharmatech Co., Ltd of Nanjing (China) and housed in specific pathogen-free environment at the Laboratory Animal Center of West China Hospital. 5 × 105 U251-luc cells in 0.9% saline containing 30% Matrigel (BD Bioscience) were injected subcutaneously into the right flanks. When tumor diameters reached ~ 2 mm five days later, mice were divided into three groups randomly. They received one of the following injections of T cells intravenously into their tail veins: 1 × 107 control (non-transduced) T cells, 1 × 107 mock-BBZ CAR-T cells, or 1 × 107 Pep42-BBZ CAR-T cells. Tumor growth was monitored once a week using an in vivo imaging software (IVIS) system (Lumina Xr, PerkinElmer, USA). Bioluminescent signals were quantified using Living Image Software (Caliper Life Science). Mice were sacrificed when the tumor volume reached approximately 2000 mm3. All protocols were approved by the animal ethics committee of the West China Hospital, SICHUAN University.
+ Open protocol
+ Expand
10

Quantifying Metastatic Tumor Growth via Luciferase Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo metastasis assays, luciferase-expressing cells were sorted with a FACSAria III (FACSDiva software (v8.0.1), BD Biosciences) using the same gate for GFP. Control and RIPK2-KO 22Rv1 cells expressing similar levels of luciferase were selected and expanded. To each male SCID/Beige mouse (7-weeks-old; Charles River #CRL:250; CB17.Cg-PrkdcscidLystbg-J/Crl), 100 µL of 1 × 107 cells/mL in DPBS was intracardially injected into the left cardiac ventricle. Each week, 150 µL of 30 mg/mL D-luciferin was intraperitoneally injected into each mouse, followed by measuring tumor metastasis with an IVIS Spectrum In Vivo Imaging System (PerkinElmer). Luciferase activity was quantified by the Living Image software (Caliper Life Sciences, v4.3.1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!